United Therapeutics Corporation (UTHR)
USD 278.91
(-4.63%)
USD 278.91
(-4.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.07 Billion USD | 15.67% |
| 2022 | 1.78 Billion USD | 14.5% |
| 2021 | 1.56 Billion USD | 13.66% |
| 2020 | 1.37 Billion USD | 3.31% |
| 2019 | 1.33 Billion USD | -6.85% |
| 2018 | 1.42 Billion USD | -11.76% |
| 2017 | 1.61 Billion USD | 6.13% |
| 2016 | 1.52 Billion USD | 9.26% |
| 2015 | 1.39 Billion USD | 20.13% |
| 2014 | 1.16 Billion USD | 17.93% |
| 2013 | 985.85 Million USD | 23.73% |
| 2012 | 796.77 Million USD | 21.78% |
| 2011 | 654.27 Million USD | 23.36% |
| 2010 | 530.36 Million USD | 63.43% |
| 2009 | 324.52 Million USD | 29.07% |
| 2008 | 251.43 Million USD | 33.26% |
| 2007 | 188.68 Million USD | 32.31% |
| 2006 | 142.6 Million USD | 37.65% |
| 2005 | 103.6 Million USD | 58.56% |
| 2004 | 65.34 Million USD | 40.34% |
| 2003 | 46.55 Million USD | 88.77% |
| 2002 | 24.66 Million USD | 850.61% |
| 2001 | 2.59 Million USD | 655.39% |
| 2000 | 343.47 Thousand USD | 134.35% |
| 1999 | -1 Million USD | -1100.0% |
| 1998 | 100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 665.8 Million USD | 4.5% |
| 2024 Q2 | 637.1 Million USD | 5.34% |
| 2024 Q1 | 604.8 Million USD | 11.24% |
| 2023 Q2 | 532.4 Million USD | 17.11% |
| 2023 Q3 | 539.3 Million USD | 1.3% |
| 2023 Q4 | 543.7 Million USD | 0.82% |
| 2023 FY | 2.07 Billion USD | 15.67% |
| 2023 Q1 | 454.6 Million USD | 4.36% |
| 2022 Q1 | 436 Million USD | 14.56% |
| 2022 FY | 1.78 Billion USD | 14.5% |
| 2022 Q4 | 435.6 Million USD | -9.02% |
| 2022 Q3 | 478.8 Million USD | 9.52% |
| 2022 Q2 | 437.2 Million USD | 0.28% |
| 2021 Q4 | 380.6 Million USD | -8.73% |
| 2021 Q2 | 409.3 Million USD | 14.94% |
| 2021 FY | 1.56 Billion USD | 13.66% |
| 2021 Q3 | 417 Million USD | 1.88% |
| 2021 Q1 | 356.1 Million USD | 1.71% |
| 2020 Q2 | 336.1 Million USD | 0.96% |
| 2020 Q4 | 350.1 Million USD | -1.68% |
| 2020 Q3 | 356.1 Million USD | 5.95% |
| 2020 FY | 1.37 Billion USD | 3.31% |
| 2020 Q1 | 332.9 Million USD | 17.92% |
| 2019 Q1 | 333.5 Million USD | -4.58% |
| 2019 FY | 1.33 Billion USD | -6.85% |
| 2019 Q2 | 346.9 Million USD | 4.02% |
| 2019 Q3 | 368.5 Million USD | 6.23% |
| 2019 Q4 | 282.3 Million USD | -23.39% |
| 2018 Q3 | 360.8 Million USD | -5.75% |
| 2018 FY | 1.42 Billion USD | -11.76% |
| 2018 Q1 | 336 Million USD | -18.39% |
| 2018 Q2 | 382.8 Million USD | 13.93% |
| 2018 Q4 | 349.5 Million USD | -3.13% |
| 2017 Q2 | 425.7 Million USD | 19.51% |
| 2017 Q4 | 411.7 Million USD | -3.36% |
| 2017 FY | 1.61 Billion USD | 6.13% |
| 2017 Q1 | 356.2 Million USD | -6.41% |
| 2017 Q3 | 426 Million USD | 0.07% |
| 2016 Q4 | 380.6 Million USD | -1.04% |
| 2016 Q2 | 392.6 Million USD | 6.6% |
| 2016 Q1 | 368.3 Million USD | -2.97% |
| 2016 FY | 1.52 Billion USD | 9.26% |
| 2016 Q3 | 384.6 Million USD | -2.04% |
| 2015 Q3 | 379.33 Million USD | 14.57% |
| 2015 FY | 1.39 Billion USD | 20.13% |
| 2015 Q4 | 379.56 Million USD | 0.06% |
| 2015 Q2 | 331.1 Million USD | 7.95% |
| 2015 Q1 | 306.72 Million USD | -7.22% |
| 2014 Q1 | 258.8 Million USD | 3.42% |
| 2014 Q3 | 289.14 Million USD | 1.78% |
| 2014 Q4 | 330.59 Million USD | 14.33% |
| 2014 Q2 | 284.09 Million USD | 9.77% |
| 2014 FY | 1.16 Billion USD | 17.93% |
| 2013 Q1 | 215.82 Million USD | 4.69% |
| 2013 FY | 985.85 Million USD | 23.73% |
| 2013 Q4 | 250.23 Million USD | -7.83% |
| 2013 Q3 | 271.5 Million USD | 9.35% |
| 2013 Q2 | 248.28 Million USD | 15.04% |
| 2012 FY | 796.77 Million USD | 21.78% |
| 2012 Q3 | 214.5 Million USD | 9.47% |
| 2012 Q1 | 180.18 Million USD | 6.08% |
| 2012 Q4 | 206.15 Million USD | -3.89% |
| 2012 Q2 | 195.94 Million USD | 8.75% |
| 2011 Q4 | 169.85 Million USD | -5.15% |
| 2011 Q2 | 162.58 Million USD | 12.79% |
| 2011 Q3 | 179.06 Million USD | 10.13% |
| 2011 FY | 654.27 Million USD | 23.36% |
| 2011 Q1 | 144.14 Million USD | -1.47% |
| 2010 Q2 | 120.8 Million USD | 5.98% |
| 2010 Q1 | 113.99 Million USD | 19.46% |
| 2010 Q3 | 149.26 Million USD | 23.55% |
| 2010 Q4 | 146.3 Million USD | -1.98% |
| 2010 FY | 530.36 Million USD | 63.43% |
| 2009 FY | 324.52 Million USD | 29.07% |
| 2009 Q4 | 95.42 Million USD | 12.98% |
| 2009 Q3 | 84.46 Million USD | 14.3% |
| 2009 Q2 | 73.89 Million USD | 4.46% |
| 2009 Q1 | 70.74 Million USD | 4.41% |
| 2008 Q2 | 61.22 Million USD | 10.99% |
| 2008 Q3 | 67.29 Million USD | 9.91% |
| 2008 Q4 | 67.75 Million USD | 0.69% |
| 2008 FY | 251.43 Million USD | 33.26% |
| 2008 Q1 | 55.16 Million USD | 3.03% |
| 2007 Q2 | 46.48 Million USD | 29.96% |
| 2007 Q4 | 53.54 Million USD | 1.25% |
| 2007 Q3 | 52.87 Million USD | 13.75% |
| 2007 Q1 | 35.77 Million USD | -12.9% |
| 2007 FY | 188.68 Million USD | 32.31% |
| 2006 Q3 | 36.24 Million USD | 0.67% |
| 2006 Q4 | 41.07 Million USD | 13.33% |
| 2006 FY | 142.6 Million USD | 37.65% |
| 2006 Q1 | 29.28 Million USD | 10.57% |
| 2006 Q2 | 36 Million USD | 22.92% |
| 2005 Q3 | 29.57 Million USD | 10.03% |
| 2005 FY | 103.6 Million USD | 58.56% |
| 2005 Q1 | 20.65 Million USD | 6.67% |
| 2005 Q2 | 26.88 Million USD | 30.17% |
| 2005 Q4 | 26.48 Million USD | -10.45% |
| 2004 FY | 65.34 Million USD | 40.34% |
| 2004 Q4 | 19.36 Million USD | 8.56% |
| 2004 Q3 | 17.83 Million USD | 9.71% |
| 2004 Q2 | 16.25 Million USD | 36.74% |
| 2004 Q1 | 11.88 Million USD | -3.43% |
| 2003 FY | 46.55 Million USD | 88.77% |
| 2003 Q4 | 12.31 Million USD | -7.32% |
| 2003 Q3 | 13.28 Million USD | 11.08% |
| 2003 Q2 | 11.95 Million USD | 32.72% |
| 2003 Q1 | 9 Million USD | -14.4% |
| 2002 Q2 | 9.65 Million USD | 1417.45% |
| 2002 FY | 24.66 Million USD | 850.61% |
| 2002 Q4 | 10.52 Million USD | 173.14% |
| 2002 Q3 | 3.85 Million USD | -60.08% |
| 2002 Q1 | 636 Thousand USD | -27.03% |
| 2001 Q3 | 456.46 Thousand USD | -22.53% |
| 2001 Q2 | 589.24 Thousand USD | -56.01% |
| 2001 FY | 2.59 Million USD | 655.39% |
| 2001 Q1 | 1.33 Million USD | 1621.41% |
| 2001 Q4 | 871.61 Thousand USD | 90.95% |
| 2000 Q3 | 151.75 Thousand USD | 2.13% |
| 2000 Q4 | 77.8 Thousand USD | -48.73% |
| 2000 FY | 343.47 Thousand USD | 134.35% |
| 2000 Q1 | -34.68 Thousand USD | -117.34% |
| 2000 Q2 | 148.59 Thousand USD | 528.44% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1999 FY | -1 Million USD | -1100.0% |
| 1999 Q4 | 200 Thousand USD | 100.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -5343.787% |
| Alkermes plc | 1.37 Billion USD | -50.581% |
| Agenus Inc. | 139.61 Million USD | -1382.649% |
| Aptorum Group Limited | -1.11 Million USD | 185802.188% |
| Ardelyx, Inc. | 106.66 Million USD | -1840.728% |
| Dyadic International, Inc. | 922.95 Thousand USD | -224179.138% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -9728.593% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1184019.288% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 15596.508% |
| Novavax, Inc. | 639.93 Million USD | -223.469% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 4519.394% |
| Pyxis Oncology, Inc. | -2 Million USD | 103600.0% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 400683.652% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -10770.136% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 4684629.737% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 392889.374% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 2207.578% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -258004.738% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2524490.244% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1430.284% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -26199.073% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 2235.121% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -36.374% |
| AlloVir, Inc. | -398 Thousand USD | 520200.503% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -759.867% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -488107.547% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1698.209% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1724900.0% |
| ChromaDex Corporation | 50.78 Million USD | -3976.408% |
| Chimerix, Inc. | 324 Thousand USD | -638788.889% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 6741.5% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2767.595% |
| CRISPR Therapeutics AG | 240.95 Million USD | -759.078% |
| Precision BioSciences, Inc. | 40.47 Million USD | -5014.647% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 2208.738% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3478.034% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3478.034% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -12387.181% |
| ImmuCell Corporation | 4.39 Million USD | -46985.22% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 2050.567% |
| Immix Biopharma, Inc. | -5468.00 USD | 37856720.337% |
| Incyte Corporation | 3.44 Billion USD | 39.837% |
| Innoviva, Inc. | 261.06 Million USD | -692.906% |
| IO Biotech, Inc. | -756 Thousand USD | 273909.524% |
| Jaguar Health, Inc. | 7.72 Million USD | -26699.586% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 311846.988% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1628.558% |
| ContextLogic Inc. | 59 Million USD | -3408.475% |
| MiMedx Group, Inc. | 266.84 Million USD | -675.737% |
| MEI Pharma, Inc. | 49.32 Million USD | -4096.485% |
| NextCure, Inc. | -3.68 Million USD | 56288.925% |
| Onconetix, Inc. | -1.12 Million USD | 183746.582% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 7245.816% |
| Opthea Limited | 21.72 Thousand USD | -9530286.74% |
| Psyence Biomedical Ltd. | -240.00 USD | 862500100.0% |
| Vaxcyte, Inc. | -75 Million USD | 2860.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3611026.979% |
| Precigen, Inc. | 106 Thousand USD | -1952730.189% |
| Pharming Group N.V. | 220.1 Million USD | -840.465% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -401841.748% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -205053.617% |
| PureTech Health plc | -1.6 Million USD | 129232.876% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1785.727% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1241.074% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 4667.016% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 9514.654% |
| Acelyrin, Inc. | -115 Thousand USD | 1800100.0% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 20595065.675% |
| Summit Therapeutics Inc. | -2.05 Million USD | 101075.61% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 362621.891% |
| Senti Biosciences, Inc. | -2.68 Million USD | 77252.441% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -50998.494% |
| Elevation Oncology, Inc. | -39 Thousand USD | 5307792.308% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 43242.976% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 52610.776% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -7006.32% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -417238.71% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3763736.364% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1888.492% |
| Seer, Inc. | 7.02 Million USD | -29357.806% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -47181.864% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -9507.798% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1747068.124% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1444611.902% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -339801.478% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1618.213% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -559.925% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 41400100.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -80319.58% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 4079721.6% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -6943.931% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 892341.379% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 420831.707% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 29263.145% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 436307.314% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 19903946.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -2127100.419% |
| Century Therapeutics, Inc. | -10.8 Million USD | 19250.708% |
| Kura Oncology, Inc. | -849 Thousand USD | 243916.254% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 3184.764% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1408263.265% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1990.086% |
| Autolus Therapeutics plc | -4.86 Million USD | 42631.333% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -4901.691% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1232242.857% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -2085.319% |
| GRI Bio, Inc. | 10.84 Million USD | -18994.18% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -81396.512% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 23928.71% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1077.984% |
| INmune Bio, Inc. | 155 Thousand USD | -1335383.871% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -3241.998% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 137523.645% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 319320.793% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 7071221.131% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -514825.373% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 103807.415% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 661441.853% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -2091.381% |
| Verastem, Inc. | -62 Thousand USD | 3338809.677% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -84910.267% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 793203.448% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -68284.539% |
| Histogen Inc. | 3.76 Million USD | -54821.73% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -359163.354% |
| Surrozen, Inc. | -27.23 Million USD | 7701.91% |
| Organovo Holdings, Inc. | -5.38 Million USD | 38511.579% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 171901.341% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 8171.119% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -10223.16% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 104545554.545% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -34022.25% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 3083623.26% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1237.287% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1419653.086% |
| Apollomics, Inc. | 127 Thousand USD | -1629821.26% |
| Amarin Corporation plc | 165.54 Million USD | -1150.446% |
| Mesoblast Limited | -9.81 Million USD | 21190.168% |
| Turnstone Biologics Corp. | 16.5 Million USD | -12440.894% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1973.49% |
| Synaptogenix, Inc. | -6347.00 USD | 32613933.307% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 4058923.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1182.806% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -17.77% |
| Better Therapeutics, Inc. | -2.72 Million USD | 75951.96% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1945.561% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -512.279% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18145261.29% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 33167.093% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 186923.105% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -28186.413% |
| Insmed Incorporated | 239.63 Million USD | -763.814% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -57753.549% |
| OmniAb, Inc. | 14.66 Million USD | -14013.316% |
| Alector, Inc. | -95.05 Million USD | 2277.732% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1547.814% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 4862.672% |
| Zai Lab Limited | 170.9 Million USD | -1111.213% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2428.183% |
| Aura Biosciences, Inc. | -1.29 Million USD | 159945.56% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1592207.692% |
| Immunic, Inc. | -111 Thousand USD | 1864964.865% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -12956.642% |
| Veracyte, Inc. | 248.14 Million USD | -734.18% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 129.618% |
| FibroGen, Inc. | 128.9 Million USD | -1505.846% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 367021376.596% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 17842.525% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 39.093% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -532033.676% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -482.532% |
| TG Therapeutics, Inc. | 219.1 Million USD | -844.74% |
| Galecto, Inc. | -830 Thousand USD | 249497.59% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 149558.484% |
| Fortrea Holdings Inc. | 424 Million USD | -388.208% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2502.312% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 365179.365% |
| XBiotech Inc. | -1.74 Million USD | 118792.661% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 186923.105% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 4554.391% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2840.488% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2720.048% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -12219.229% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -432.079% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 4269.436% |
| Vaxxinity, Inc. | -2.23 Million USD | 92758.908% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -533.51% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 18380.015% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -8365.911% |
| NexImmune, Inc. | -1.02 Million USD | 202056.736% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -38333233.333% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 29231.723% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 81.684% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 3097650.391% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 58393.438% |
| Ainos, Inc. | -253.73 Thousand USD | 815918.203% |
| Pluri Inc. | 322 Thousand USD | -642757.143% |
| Prothena Corporation plc | -129.2 Million USD | 1702.155% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -4005.193% |
| Celularity Inc. | 6.75 Million USD | -30543.967% |
| Rallybio Corporation | -150 Thousand USD | 1380100.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 6448.33% |
| MeiraGTx Holdings plc | 287 Thousand USD | -721154.355% |
| Omeros Corporation | -69.77 Million USD | 3066.509% |
| Humacyte, Inc. | -76.55 Million USD | 2804.115% |
| Immunocore Holdings plc | 248.39 Million USD | -733.364% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 13746.252% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -3218.265% |
| Blueprint Medicines Corporation | 236.58 Million USD | -774.954% |
| CalciMedica, Inc. | -58 Thousand USD | 3569065.517% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 145261.29% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -7024.419% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 72884.81% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 6806.626% |
| Pulmatrix, Inc. | -8.22 Million USD | 25282.482% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 177023.077% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 518896.992% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 619.065% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -74478.873% |
| Cytokinetics, Incorporated | -322.59 Million USD | 741.675% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -240009.963% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 607138.123% |
| Vor Biopharma Inc. | -3.49 Million USD | 59378.351% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1794.997% |
| Evogene Ltd. | 1.39 Million USD | -147862.831% |
| ProKidney Corp. | -3.16 Million USD | 65420.29% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4813.973% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -30088.129% |
| CorMedix Inc. | -205.56 Thousand USD | 1007095.456% |
| BioLineRx Ltd. | 1.1 Million USD | -186723.105% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2731.211% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 6272827.273% |
| Atai Life Sciences N.V. | -5000.00 USD | 41400100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1698784.545% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 2156350.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 149128.078% |
| Sagimet Biosciences Inc. | 2 Million USD | -103400.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -211188.092% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2554.963% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2189302.052% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10089.978% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -746.505% |
| Biomea Fusion, Inc. | -4.2 Million USD | 49373.982% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -137.294% |
| Mereo BioPharma Group plc | 7.42 Million USD | -27775.034% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 667841.935% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 17250100.0% |
| Absci Corporation | -41.84 Million USD | 5046.355% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 41400100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2810.382% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 84212.15% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -868.489% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 220078.746% |
| Allakos Inc. | -6.14 Million USD | 33807.865% |
| Imunon, Inc. | -720 Thousand USD | 287598.003% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 3100.174% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -334.971% |
| BioAtla, Inc. | -103.73 Million USD | 2095.546% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18145261.29% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1163021.348% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 952.487% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 665694.855% |
| XOMA Corporation | 3.86 Million USD | -53513.054% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 3053.556% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -13892.159% |
| aTyr Pharma, Inc. | -2.38 Million USD | 86783.417% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -16513.162% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 7138031.034% |
| Viridian Therapeutics, Inc. | -1 Million USD | 205457.143% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -15923076823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 51750100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -225.016% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1063030.431% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2722.009% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 7854.552% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -17829357.364% |
| Orgenesis Inc. | -5.72 Million USD | 36257.205% |
| Entera Bio Ltd. | -56 Thousand USD | 3696528.571% |
| GH Research PLC | -315 Thousand USD | 657242.857% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1095338.095% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 394385.714% |
| Xencor, Inc. | -85.26 Million USD | 2527.868% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 936849.073% |
| Replimune Group, Inc. | -2.65 Million USD | 78066.102% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 206844.464% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1063.941% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1063030.431% |
| Portage Biotech Inc. | -54 Thousand USD | 3833433.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2189302.052% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 549171.618% |
| OncoCyte Corporation | 413 Thousand USD | -501110.654% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 46051267.964% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 932432532.432% |
| Purple Biotech Ltd. | -196 Thousand USD | 1056222.449% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -22982.07% |
| scPharmaceuticals Inc. | 9.78 Million USD | -21061.317% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 19918.176% |
| HilleVax, Inc. | -2.15 Million USD | 96111.132% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 2134120.619% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 13796420.981% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 309980.24% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 9000100.0% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 27577449.803% |
| Savara Inc. | -44.26 Million USD | 4776.698% |
| Curis, Inc. | 9.81 Million USD | -20998.767% |
| Daré Bioscience, Inc. | 2.76 Million USD | -74642.14% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1658913.347% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 119822.383% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 907994.737% |
| BeiGene, Ltd. | 2.07 Billion USD | 0.426% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 74136.983% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 617.935% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3551.566% |
| Erasca, Inc. | -3.73 Million USD | 55566.238% |
| bluebird bio, Inc. | -4.03 Million USD | 51464.764% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7335843.143% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -8.697% |
| DBV Technologies S.A. | 15.72 Million USD | -13061.241% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7335843.143% |
| Moderna, Inc. | 2.15 Billion USD | 3.944% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 226329.508% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -25755.608% |
| Molecular Templates, Inc. | 50.39 Million USD | -4007.55% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 386294.03% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1447.224% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 33369.045% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 5361.419% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1962.717% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 57792.308% |
| MacroGenics, Inc. | 50.52 Million USD | -3996.82% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 34045.556% |
| Prime Medicine, Inc. | -147.9 Million USD | 1499.547% |
| Aditxt, Inc. | -111.66 Thousand USD | 1853942.02% |
| Adagene Inc. | 18.11 Million USD | -11329.208% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -424080.328% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1376.441% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1211.488% |
| SciSparc Ltd. | 2.19 Million USD | -94162.295% |
| Vericel Corporation | 135.57 Million USD | -1426.819% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8263902.946% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 6681398.819% |
| Generation Bio Co. | -73.91 Million USD | 2900.666% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 473784.211% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3689.89% |
| Invivyd, Inc. | -2.02 Million USD | 102171.006% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 788.071% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 2001298.786% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -2048.016% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -2006.056% |
| ADMA Biologics, Inc. | 88.21 Million USD | -2246.46% |
| Clene Inc. | 533 Thousand USD | -388267.73% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -8485.94% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 216400.94% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10089.978% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -104024.748% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1065375.119% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -4056.209% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 29287.817% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 247707.656% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2381.568% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2831172.568% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3793.759% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1295.233% |
| Trevena, Inc. | 1.45 Million USD | -142168.041% |
| Surrozen, Inc. | -27.23 Million USD | 7701.91% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 586502.266% |
| Cingulate Inc. | -582.91 Thousand USD | 355209.981% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 6677519.355% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 10608.148% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 27344882.034% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 235060.272% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -204.096% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 209614.17% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3674090.984% |
| Kronos Bio, Inc. | 1.37 Million USD | -150774.636% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 3957.191% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 709004.11% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 424007.568% |
| ImmunityBio, Inc. | -17.89 Million USD | 11670.71% |
| Korro Bio, Inc. | -3.63 Million USD | 57124.793% |
| Kineta, Inc. | 5.43 Million USD | -38000.497% |
| BioVie Inc. | -229.37 Thousand USD | 902544.447% |
| Codexis, Inc. | 57.33 Million USD | -3510.423% |
| Celularity Inc. | 6.75 Million USD | -30543.967% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -51482.357% |
| Celcuity Inc. | -142.77 Thousand USD | 1449964.119% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -4091617.731% |
| Cibus, Inc. | 1.42 Million USD | -145469.62% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 553575.936% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 9131.808% |
| IN8bio, Inc. | -2.5 Million USD | 82866.893% |
| Kodiak Sciences Inc. | -25.94 Million USD | 8077.801% |
| Annexon, Inc. | -3.26 Million USD | 63460.882% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 101372.016% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 5059.628% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -323337.5% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -165.891% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1096.843% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 109047.368% |
| Arcellx, Inc. | 108.27 Million USD | -1811.728% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 6495.008% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2513.504% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 9886.309% |
| Moolec Science SA | -143.3 Thousand USD | 1444571.582% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 4991.536% |
| Geron Corporation | -123.5 Million USD | 1776.073% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -62875.357% |
| Royalty Pharma plc | 1.79 Billion USD | -15.391% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 3053.346% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 57309070.1% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -894489.677% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1957.935% |
| Humacyte, Inc. | -76.55 Million USD | 2804.115% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 218184.355% |
| 89bio, Inc. | -273 Thousand USD | 758341.758% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 164777.804% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 244203.774% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1683026.829% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -184886.595% |
| Notable Labs, Ltd. | 113 Thousand USD | -1831758.407% |
| Liquidia Corporation | 14.6 Million USD | -14078.082% |
| Mustang Bio, Inc. | -2.22 Million USD | 93133.708% |
| Immunovant, Inc. | -231 Thousand USD | 896203.896% |
| Quantum-Si incorporated | 488 Thousand USD | -424080.328% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3825.769% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 6900100.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -111070.784% |
| Acasti Pharma Inc. | -11 Thousand USD | 18818281.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1011746.149% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 319320.793% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1335.732% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -182346.368% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 543407.087% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 105820.123% |
| PepGen Inc. | -1.18 Million USD | 174931.081% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1630021.26% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 9140.486% |
| Solid Biosciences Inc. | -76.56 Million USD | 2803.656% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2506669.149% |
| Immuneering Corporation | -764.13 Thousand USD | 270993.477% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -3123768.164% |
| Belite Bio, Inc | -399 Thousand USD | 518896.992% |
| XOMA Corporation | 3.86 Million USD | -53513.054% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 10431.403% |
| Bionomics Limited | -434.44 Thousand USD | 476565.592% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 192837.43% |
| uniQure N.V. | 2.21 Million USD | -93353.725% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2414.841% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2348.314% |
| Forte Biosciences, Inc. | -9000.00 USD | 23000100.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 248004.192% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 473784.211% |
| Altimmune, Inc. | -65.37 Million USD | 3266.445% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -471.776% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 192837.43% |
| Compugen Ltd. | 31.45 Million USD | -6480.83% |
| Peak Bio, Inc. | 367.76 Thousand USD | -562753.313% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -8343.465% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1916566.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2653946.154% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 172169.825% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 113711.416% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1739595.798% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 172169.825% |
| Instil Bio, Inc. | -4.75 Million USD | 43623.97% |
| argenx SE | 1.1 Billion USD | -86.742% |
| Immunome, Inc. | -8.9 Million USD | 23340.148% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 109623.81% |
| Verona Pharma plc | -679.62 Thousand USD | 304680.18% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1182957.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 86892.453% |
| CervoMed Inc. | -1.29 Million USD | 160115.213% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 86099.169% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 43432.636% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -83671.752% |
| Moolec Science SA | -143.3 Thousand USD | 1444571.582% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 507415.639% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 77583.747% |
| AnaptysBio, Inc. | 14.78 Million USD | -13904.465% |
| Design Therapeutics, Inc. | -537 Thousand USD | 385574.86% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 484877.518% |
| NeurAxis, Inc. | 2.15 Million USD | -95879.791% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -96358.527% |
| Lumos Pharma, Inc. | 2 Million USD | -103039.013% |
| Achilles Therapeutics plc | -4.73 Million USD | 43851.494% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1182957.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1958936.054% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -6438.476% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -240009.963% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 200681.395% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 4644.656% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -4813853.488% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 251924.818% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 15731974.145% |
| Palisade Bio, Inc. | 246 Thousand USD | -841363.415% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 6272827.273% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3568.964% |
| Neurogene Inc. | -3.26 Million USD | 63558.001% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1385.628% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 56167.172% |
| Sesen Bio, Inc. | 40 Million USD | -5075.0% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 697069.697% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 51502.557% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 21739.139% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -14601.705% |
| Athira Pharma, Inc. | -969 Thousand USD | 213722.291% |
| Vaccinex, Inc. | -16 Million USD | 13034.266% |
| HCW Biologics Inc. | -574.82 Thousand USD | 360210.225% |
| XOMA Corporation | 3.86 Million USD | -53513.054% |
| Nektar Therapeutics | 53.47 Million USD | -3770.751% |
| Arvinas, Inc. | 71.8 Million USD | -2783.008% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 2580.2% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 3397.491% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 642957.143% |
| Rezolute, Inc. | -36 Thousand USD | 5750100.0% |
| Clene Inc. | 533 Thousand USD | -388267.73% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 161215053.271% |
| BeyondSpring Inc. | 1.75 Million USD | -118118.161% |
| Synlogic, Inc. | -1.92 Million USD | 107688.358% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 5594694.595% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 32791.093% |
| Peak Bio, Inc. | 367.76 Thousand USD | -562753.313% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 11015.994% |
| Krystal Biotech, Inc. | 47.6 Million USD | -4248.283% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1367.138% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -41094.03% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 80046.887% |
| MannKind Corporation | 136.19 Million USD | -1419.924% |
| Ikena Oncology, Inc. | -50.49 Million USD | 4199.659% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1802.329% |
| Gossamer Bio, Inc. | -4.38 Million USD | 47306.385% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 821528.571% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 41400100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1368.825% |
| Mural Oncology plc | -2.56 Million USD | 80738.878% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 375780.581% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 2070100.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -9873.981% |
| REGENXBIO Inc. | 53.02 Million USD | -3803.524% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 38741.369% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1076123.392% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 119615.012% |
| Vaxart, Inc. | -60.76 Million USD | 3506.678% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 787831.182% |
| Cellectis S.A. | 18 Thousand USD | -11499900.0% |
| Longeveron Inc. | 221 Thousand USD | -936551.584% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2685.238% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -89.388% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 160069.088% |
| Revolution Medicines, Inc. | -399.66 Million USD | 617.935% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 5914385.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -4224389.796% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 75.95% |
| Denali Therapeutics Inc. | -93.34 Million USD | 2317.58% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8263902.946% |
| Veru Inc. | 7.56 Million USD | -27259.499% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1370960.927% |
| Cingulate Inc. | -582.91 Thousand USD | 355209.981% |
| Passage Bio, Inc. | -3.72 Million USD | 55730.207% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 17187081.069% |
| Exicure, Inc. | -1.42 Million USD | 145567.323% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 540569.974% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -76481.576% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 403864.568% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2938.488% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1383725.098% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3596.267% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -529311.765% |
| OmniAb, Inc. | 14.66 Million USD | -14013.316% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -10253.624% |
| Lipocine Inc. | -2.85 Million USD | 72710.738% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 112416.875% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 36383.961% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 137523.645% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2648.42% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 3184715.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -2355.633% |
| Ocugen, Inc. | -33.53 Million USD | 6272.287% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 65564.896% |
| Q32 Bio Inc. | 578 Thousand USD | -358031.488% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 781232.075% |
| Alumis Inc. Common Stock | -1.28 Million USD | 161314.953% |
| Equillium, Inc. | 35.95 Million USD | -5656.716% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 121365.378% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -413338.55% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 50072668.94% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 799327.799% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -489595.112% |
| Dominari Holdings Inc. | 2.03 Million USD | -101420.353% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1128343.701% |
| vTv Therapeutics Inc. | -13.59 Million USD | 15326.186% |
| Bio-Techne Corporation | 773.07 Million USD | -167.762% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -11852.191% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -349.232% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 177174.423% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 8732.193% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -17596.845% |
| Nkarta, Inc. | -5.86 Million USD | 35370.063% |
| BioCardia, Inc. | -7.24 Million USD | 28655.663% |
| Iterum Therapeutics plc | -1.75 Million USD | 118385.714% |